BetterLife Pharma annual net debt
2018
2019
2020
2021
2022
2023
2024
2025
2026
BetterLife Pharma Net Debt Growth & History (BETRF)
BetterLife Pharma's net debt was $1.2M for fiscal 2026.
View full BetterLife Pharma company overviewBetterLife Pharma annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | $1.2M | −$81,483 | −6.30% |
| 2025 | 2025-01-31 | $1.3M | $1.2M | +1994.38% |
| 2024 | 2024-01-31 | $61,783 | −$9,910 | −13.82% |
| 2023 | 2023-01-31 | $71,693 | −$4.5M | −98.44% |
| 2022 | 2022-01-31 | $4.6M | $4.8M | — |
| 2021 | 2021-01-31 | −$154,722 | −$1.6M | — |
| 2020 | 2020-01-31 | $1.4M | −$280,727 | −16.50% |
| 2019 | 2019-01-31 | $1.7M | $1.8M | — |
| 2018 | 2018-01-31 | −$79,304 | — | — |
BetterLife Pharma quarterly net debt
Q4.18
Q1.19
Q4.19
Q1.20
Q4.20
Q4.21
Q4.22
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-04-30 | $1.0M | −$276,863 | −21.54% |
| Q4 2026 | 2026-01-31 | $1.2M | — | — |
| Q3 2026 | 2025-10-31 | $1.0M | — | — |
| Q2 2026 | 2025-07-31 | $1.0M | — | — |
| Q1 2026 | 2025-04-30 | $1.3M | — | — |
| Q4 2022 | 2022-01-31 | $4.6M | $4.8M | — |
| Q4 2021 | 2021-01-31 | −$154,722 | −$1.6M | — |
| Q4 2020 | 2020-01-31 | $1.4M | −$280,727 | −16.50% |
| Q1 2020 | 2019-04-30 | $1.1M | $3.0M | — |
| Q4 2019 | 2019-01-31 | $1.7M | $1.8M | — |
| Q1 2019 | 2018-04-30 | −$1.9M | — | — |
| Q4 2018 | 2018-01-31 | −$79,304 | — | — |
BetterLife Pharma net debt trends
Over the last five fiscal years, BetterLife Pharma's net debt increased from −$154,722 to $1.2M, a change of $1.4M. The latest reported quarter, Q1 2027, shows $1.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BetterLife Pharma source filings ↗